#  eye Insights 14: Genetic Therapies for Inherited Retinal Disorders 

 



 ##  

  expand\_more  

 
  

 

   ![Eye Insights 14](/sites/g/files/omnuum9886/files/styles/hwp_1_1__100x100_scale/public/eye/files/irds_eye_insights_cover_01.png?itok=C5pbpdbq) 

 

While gene therapy is not yet widely available for inherited retinal disorsers (IRDs), researchers are making exciting discoveries, and the future looks more promising than ever before. In this issue of *eye Insights*, we provide a look into current offerings in gene therapy, and a glimpse into the exciting prospects brought forth by clinical trials being led by our own researchers at Mass Eye and Ear. **Inside**

- IRDs and genetic testing
- Current gene therapies for IRDs
- Access to clinical trials
- Treatment and outcomes

 *Editor-in-Chief: Joan W. Miller, MD   
Managing Editor: Matthew F. Gardiner, MD  
Clinical Advisory Group: Deeba Husain, MD; Alice Lorch, MD, MPH; Ankoor Shah, MD, PhD  
Publications Manager: Jessica O’Donnell   
Graphic Design: Stone Studio Design  
Contributor: Rachel M. Huckfeldt, MD, PhD*

 [Browse all issues &gt; &gt;](/documents/newsletter/eye-insights) | Email: <eyeinsights@meei.harvard.edu>



 

---

 Attachments- [  picture\_as\_pdf  eye Insights 14 Inherited Retinal Disorders.pdf ](/sites/g/files/omnuum9886/files/eye/files/eye_insights_14_inherited_retinal_disorders.pdf)
 
---

 



 

 See also:- [ eye Insights ](/newsletter/eye-insights)